Cullen Enhanced Equity Income Fund BMY Holdings History
Cullen Enhanced Equity Income Fund's Bristol-Myers Squibb Co Holding Summary
As of 2025-03-31, CULLEN FUNDS TRUST held 96,000.00 shares of Bristol-Myers Squibb Co(BMY), totaling $5.86 Mil. This investment constitutes 3.76% of their stock portfolio, and CULLEN FUNDS TRUST now holds 0% of the outstanding Bristol-Myers Squibb Co(BMY) stock.
The initial trade took place in 2020Q4. And since then Cullen Enhanced Equity Income Fund has made 9 purchases of BMY, at an average price of $64.92, for a total of 156,502.00 shares. In addition, there have been 6 sales at an average price of $55.43 for 60,502.00 shares. Based on historical transaction data and BMY's current price of $48.94, Cullen Enhanced Equity Income Fund's estimated gain on his BMY holdings is $-2.11 Mil, reflecting a -20.75% gain to date.
Cullen Enhanced Equity Income Fund BMY ($48.94) Holding Chart
Cullen Enhanced Equity Income Fund BMY ($48.94) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
